Compare, Analyse SHASUN PHARMA with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SHASUN PHARMA   ACTAVIS
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
ACTAVIS
Dec-18
SHASUN PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs9413,781-   
Low Rs469,244-   
Sales per share (Unadj.) Rs214.23,380.5-  
Earnings per share (Unadj.) Rs5.3-1,088.9-  
Cash flow per share (Unadj.) Rs15.8356.2-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %1.40-  
Book value per share (Unadj.) Rs53.313,942.9-  
Shares outstanding (eoy) m56.62332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.4 9.6%   
Avg P/E ratio x13.1-10.6 -123.9%  
P/CF ratio (eoy) x4.432.3 13.7%  
Price / Book Value ratio x1.30.8 158.7%  
Dividend payout %18.70-   
Avg Mkt Cap Rs m3,9583,829,128 0.1%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m2,1640-   
Avg. sales/employee Rs ThNM66,529.6-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM-21,429.2-  
INCOME DATA
Net Sales Rs m12,1271,124,350 1.1%  
Other income Rs m22921,501 1.1%   
Total revenues Rs m12,3561,145,851 1.1%   
Gross profit Rs m1,00929,464 3.4%  
Depreciation Rs m594480,635 0.1%   
Interest Rs m41564,881 0.6%   
Profit before tax Rs m230-494,552 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0126,131 0.0%   
Tax Rs m-73-6,267 1.2%   
Profit after tax Rs m302-362,154 -0.1%  
Gross profit margin %8.32.6 317.5%  
Effective tax rate %-31.71.3 -2,498.2%   
Net profit margin %2.5-32.2 -7.7%  
BALANCE SHEET DATA
Current assets Rs m6,884461,150 1.5%   
Current liabilities Rs m8,456407,948 2.1%   
Net working cap to sales %-13.04.7 -273.9%  
Current ratio x0.81.1 72.0%  
Inventory Days Days6220 314.7%  
Debtors Days Days10866 162.2%  
Net fixed assets Rs m4,970127,270 3.9%   
Share capital Rs m1130-   
"Free" reserves Rs m2,8750-   
Net worth Rs m3,0204,637,419 0.1%   
Long term debt Rs m1,8171,633,003 0.1%   
Total assets Rs m13,3477,249,341 0.2%  
Interest coverage x1.6-6.6 -23.5%   
Debt to equity ratio x0.60.4 170.9%  
Sales to assets ratio x0.90.2 585.8%   
Return on assets %5.4-4.1 -131.0%  
Return on equity %10.0-7.8 -128.1%  
Return on capital %13.3-4.8 -275.2%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Net fx Rs m3,6690-   
CASH FLOW
From Operations Rs m398401,688 0.1%  
From Investments Rs m-1,635220,675 -0.7%  
From Financial Activity Rs m1,309-689,417 -0.2%  
Net Cashflow Rs m71-66,719 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 71.22 Rs / USD

Compare SHASUN PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SHASUN PHARMA With: FDC LTD.  BIOCON   WOCKHARDT  DISHMAN PHARMA  IPCA LABS  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 5-YR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS